Abstract
Humans with merosin-deficient congenital muscular dystrophy have both sucking problems during infancy and sleep-disordered breathing during childhood. We hypothesized that merosin-deficient pharyngeal muscles fatigue faster than normal muscles. This was tested in vitro using sternohyoid muscle from an animal model of this disease, the dy/dy dystrophic mouse. Isometric twitch contraction and half-relaxation times were similar for dy/dy and normal sternohyoid. However, rate of force loss during repetitive 25-Hz train stimulation was markedly diminished in dystrophic compared with normal sternohyoid muscle. Furthermore, force potentiation, which occurred during the early portion of the fatigue-inducing stimulation, had a longer duration in dystrophic compared with normal muscle (approximately 60 versus 20 s). As a result of these two processes, at the end of 2 min of stimulation, force of dystrophic muscle had decreased by 8 ± 5% and that of normal muscle by 69 ± 4% (p < 0.0001). The potassium-channel blocker, 3,4-diaminopyridine, increased force of dy/dy sternohyoid muscle during twitch and 25-Hz contractions by 148 ± 20% (p < 0.00001) and 109 ± 18% (p < 0.00002), respectively. During repetitive 25-Hz stimulation, force of 3,4-diaminopyridine-treated dystrophic muscle remained significantly higher than that of untreated muscle, despite the early force potentiation being eliminated and fatigue being accelerated. Thus, merosin deficiency reduces fatigue and prolongs the duration of force potentiation. The latter alterations may partially preserve the integrity of upper airway muscle function, without which the severity of pharyngeal complications (feeding problems, sleep-related respiratory dysfunction) might be even more pronounced in the human merosin-deficient congenital muscular dystrophies.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- DAP:
-
3,4-diaminopyridine
References
Voit T 1998 Congenital muscular dystrophies: 1997 update. Brain Dev 20: 65–74
Khan Y, Heckmatt JZ, Dubowitz V 1996 Sleep studies and supportive ventilatory treatment in patients with congenital muscle disorders. Arch Dis Child 74: 195–200
Michelson AM, Russell ES, Harman PJ 1955 Dystrophia muscularis: a hereditary primary myopathy in the house mouse. Proc Natl Acad Sci USA 41: 1079–1084
Xu H, Christmas P, Wu XR, Wewer UM, Engvall E 1994 Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci USA 91: 5572–5576
Hayes A, Williams DA 1998 Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse: I. Clenbuterol. J Neurol Sci 157: 122–128
van Lunteren E, Manubay P 2001 Inotropic effects of the K+channel blocker TEA on dystrophic (mdx and dy/dy) mouse diaphragm. Respir Physiol 125: 249–254
Dangain J, Neering I 1992 Mouse models of muscular dystrophy: gene products and function. News Physiol Sci 7: 195–199
Connolly AM, Keeling RM, Mehta S, Pstronk A, Sanes JR 2001 Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin α2-deficient mice. Neuromuscul Disord 11: 703–712
Bulfield G, Siller WG, Wight PAL, Moore KJ 1994 X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81: 1189–1192
Sicinski P, Geng Y, Ryder-Cook AS, Bernard EA, Darlison MG, Barnard PJ 1989 The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244: 1578–1580
Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT, Kelly AM 1991 The MDX mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 342: 536–538
Dupont-Versteegden EE, McCarter RJ 1992 Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of MDX mice. Muscle Nerve 15: 1105–1110
van Lunteren E, Moyer M 2002 Improvement of dy/dy dystrophic diaphragm by K+ channel blocker 3,4-diaminopyridine. Muscle Nerve 26: 71–78
van Lunteren E, Vafaie H, Moyer M 1995 Changes in pharyngeal respiratory muscle force produced by K+ channel blockade. Respir Physiol 99: 331–340
Attal P, Lambert F, Marchand-Adam S, Bobin S, Pourny J, Chemla D, LeCarpentier Y, Coirault C 2000 Severe mechanical dysfunction in pharyngeal muscle from adultmdxmice. Am J Respir Crit Care Med 162: 278–281
van Lunteren E, Vafaie H 1993 Force potentiation in respiratory muscles: comparison of diaphragm and sternohyoid. Am J Physiol 264: R1095–R1100
van Lunteren E, Vafaie H, Salomone RJ 1995 Comparative effects of aging on pharyngeal and diaphragm muscles. Respir Physiol 99: 113–125
Emery AEH 2002 The muscular dystrophies. Lancet 359: 687–695
Burke RE, Levine DN, Zajac FE 1971 Mammalian motor units: physiological-histochemical correlation in three types of rat gastrocnemius. Science 174: 709–712
Burke RE, Levine DN, Tsairis P, Zajac FE 1973 Physiological types and histochemical profiles in motor units of the cat gastrocnemius. J Physiol Lond 234: 723–748
Fournier M, Sieck GC 1988 Mechanical properties of muscle units in the cat diaphragm. J Neurophysiol 59: 1055–1066
Kuei JH, Shadmehr R, Sieck GC 1990 Relative contribution of neurotransmission failure to diaphragm fatigue. J Appl Physiol 68: 174–180
van Lunteren E, Moyer M, Torres A 1995 Effect of K+ channel blockade on fatigue in rat diaphragm muscle. J Appl Physiol 79: 738–747
van Lunteren E, Moyer M 1996 Effects of DAP on diaphragm force and fatigue, including fatigue due to neurotransmission failure. J Appl Physiol 81: 2214–2220
van Lunteren E, Dick TE 1989 Motor unit regulation of mammalian pharyngeal dilator muscle activity. J Clin Invest 84: 577–585
van Lunteren E, Haxhiu MA, Cherniack NS 1987 Mechanical function of hyoid muscles during spontaneous breathing in cats. J Appl Physiol 62: 582–590
Edwards JP, Hatton PA, Wareham AC 1998 Electrophysiology of the neuromuscular junction of the laminin-2 (merosin) deficient C57 BL/6J dy2J/dy2J dystrophic mouse. Brain Res 788: 262–268
Williams JH 1990 Depression of posttetanic twitch potentiation by low calcium and calcium channel antagonists. J Appl Physiol 69: 1093–1097
Gillis JM 1999 Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse. J Muscle Res Cell Motil 20: 605–625
Quinlan JG, Johnson SR, McKee MK, Lyden SP 1992 Twitch and tetanus in mdx mouse muscle. Muscle Nerve 15: 837–842
van Lunteren E, Moyer M, Dick TE 2001 Modulation of diaphragm action potentials by K+ channel blockers. Respir Physiol 124: 217–230
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by a Merit Review Grant from the Department of Veterans Affairs, U.S.A.
Rights and permissions
About this article
Cite this article
van Lunteren, E., Moyer, M. Sternohyoid Muscle Fatigue Properties of dy/dy Dystrophic Mice, an Animal Model of Merosin-Deficient Congenital Muscular Dystrophy. Pediatr Res 54, 547–553 (2003). https://doi.org/10.1203/01.PDR.0000081762.51546.16
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/01.PDR.0000081762.51546.16
